Protocol for the implantation of a venous access device (Port-A-Cath System). The complications and solutions found in 560 cases
暂无分享,去创建一个
[1] A. C. Ibañez,et al. Experiencia clínica con reservorios venosos subcutáneoos en pacientes oncológicos , 2004, Revista de Oncología.
[2] B. Burbridge,et al. Arm placement of the Cook titanium Petite Vital-Port: results of radiologic placement in 125 patients with cancer. , 2000, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[3] W. Kistler,et al. [Experiences with the Port-A-Cath system in children]. , 2000, Schweizerische medizinische Wochenschrift.
[4] J. Olsen,et al. Long-term follow-up of upper extremity implanted venous access devices in oncology patients. , 1999, Journal of vascular and interventional radiology : JVIR.
[5] M. Intra,et al. Complications of Subcutaneous Infusion Port in the General Oncology Population , 1999, Oncology.
[6] J. Thornby,et al. Infectious complications of 393 peripherally implantable venous access devices in HIV-positive and HIV-negative patients. , 1999, Journal of vascular and interventional radiology : JVIR.
[7] M. Piver,et al. Complications related to indwelling caval catheters on a gynecologic oncology service. , 1998, Gynecologic oncology.
[8] T. Nøstdahl,et al. Costoclavicular pinching: a complication of long‐term central venous catheters: A report of three cases , 1998, Acta anaesthesiologica Scandinavica.
[9] R. Kester,et al. Five years' experience of PAS Port intravenous access system in adult cystic fibrosis. , 1998, The European respiratory journal.
[10] C. Petersen,et al. [Central venous indwelling catheter systems in pediatric oncology from the surgical viewpoint]. , 1998, Klinische Padiatrie.
[11] C. Barrat. Mise en place chirurgicale d'un site implantable : Indications - avantages - complications précoces , 1998 .
[12] J. Fuchs,et al. Zentralvense Verweilsysteme in der pdiatrischen Onkologie aus chirurgischer Sicht , 1998 .
[13] B. Gmeinhart,et al. [Management of HIV infected patients: applicability of guidelines. Results of an nationwide Austrian survey]. , 1998, Acta medica Austriaca.
[14] M. King,et al. A phase I trial of retroviral BRCA1sv gene therapy in ovarian cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[15] B. Ardalan,et al. A new complication of chemotherapy administered via permanent indwelling central venous catheter , 1995, Cancer.
[16] R. Edwards,et al. Spontaneous fracture of the outlet catheter of a totally implanted catheter system (Port-A-Cath) , 1994, The International journal of artificial organs.
[17] L. Miller,et al. Outpatient dobutamine for end‐stage congestive heart failure , 1990, Critical care medicine.